Wikidata entity: Q47495698
C₂₁H₃₅N₃O₇ (P274)
Quantities
| P2067 | mass | 441.247498 |
| P3780 | active ingredient in | ... | Q47521773 (Zestril) | Zestril |
| P3780 | active ingredient in | ... | Q47522050 (Qbrelis) | Qbrelis |
| P3780 | active ingredient in | ... | Q48829297 (Prinivil) | Prinivil |
| P233 | canonical SMILES | String | NCCCCC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O.O.O | ??? |
| P4770 | hydrated form of | ... | Q412208 (lisinopril) | lisinopril |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | O.O.NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N2CCC[C@H]2C(O)=O | ??? |
| P2175 | medical condition treated | ... | Q41861 (arterial hypertension) | arterial hypertension |
| P1748 | NCI Thesaurus ID | String | C29159 | ??? |
| P769 | significant drug interaction | ... | Q45050 (tenoxicam) | tenoxicam |
| P769 | significant drug interaction | ... | Q155472 (valsartan) | valsartan |
| P769 | significant drug interaction | ... | Q186969 (ibuprofen) | ibuprofen |
| P769 | significant drug interaction | ... | Q275926 (bumetanide) | bumetanide |
| P769 | significant drug interaction | ... | Q221520 (triamterene) | triamterene |
| P769 | significant drug interaction | ... | Q244408 (Diclofenac) | Diclofenac |
| P769 | significant drug interaction | ... | Q409192 ((RS)-ketoprofen) | (RS)-ketoprofen |
| P769 | significant drug interaction | ... | Q409231 (indomethacin) | indomethacin |
| P769 | significant drug interaction | ... | Q347941 (parecoxib) | parecoxib |
| P769 | significant drug interaction | ... | Q367700 (cyclosporine) | cyclosporine |
| P769 | significant drug interaction | ... | Q388801 (furosemide) | furosemide |
| P769 | significant drug interaction | ... | Q408676 (piroxicam) | piroxicam |
| P769 | significant drug interaction | ... | Q408801 (celecoxib) | celecoxib |
| P769 | significant drug interaction | ... | Q413581 (bromocriptine) | bromocriptine |
| P769 | significant drug interaction | ... | Q414028 (meloxicam) | meloxicam |
| P769 | significant drug interaction | ... | Q415970 (candesartan) | candesartan |
| P769 | significant drug interaction | ... | Q419890 ((±)-flurbiprofen) | (±)-flurbiprofen |
| P769 | significant drug interaction | ... | Q419995 (amiloride) | amiloride |
| P769 | significant drug interaction | ... | Q421156 (olmesartan) | olmesartan |
| P769 | significant drug interaction | ... | Q422188 (spironolactone) | spironolactone |
| P769 | significant drug interaction | ... | Q422665 (trimethoprim) | trimethoprim |
| P769 | significant drug interaction | ... | Q410074 (losartan) | losartan |
| P769 | significant drug interaction | ... | Q425289 (chlorthalidone) | chlorthalidone |
| P769 | significant drug interaction | ... | Q963093 (sulindac) | sulindac |
| P769 | significant drug interaction | ... | Q1078392 (indapamide) | indapamide |
| P769 | significant drug interaction | ... | Q1169164 ((RS)-bendroflumethiazide) | (RS)-bendroflumethiazide |
| P769 | significant drug interaction | ... | Q1215575 (naproxen) | naproxen |
| P769 | significant drug interaction | ... | Q27074832 (azilsartan) | azilsartan |
| P769 | significant drug interaction | ... | Q2465218 ((RS)-etodolac) | (RS)-etodolac |
| P769 | significant drug interaction | ... | Q2555245 ((RS)-fenoprofen) | (RS)-fenoprofen |
| P769 | significant drug interaction | ... | Q5135114 ((2RS,6RS)-clopamide) | (2RS,6RS)-clopamide |
| P769 | significant drug interaction | ... | Q423804 (eplerenone) | eplerenone |
| P769 | significant drug interaction | ... | Q423930 (hydrochlorothiazide) | hydrochlorothiazide |
| P769 | significant drug interaction | ... | Q425207 (nabumetone) | nabumetone |
| P769 | significant drug interaction | ... | Q733186 (telmisartan) | telmisartan |
| P769 | significant drug interaction | ... | Q784717 (eprosartan) | eprosartan |
| P769 | significant drug interaction | ... | Q947266 (irbesartan) | irbesartan |
| P279 | subclass of | ... | Q462174 (hydrate) | hydrate |
| P2868 | subject has role | ... | Q288280 (ACE inhibitor) | ACE inhibitor |
| P231 | CAS Registry Number | 83915-83-7 |
| P683 | ChEBI ID | 6503 |
| P661 | ChemSpider ID | 4514932 |
| P8494 | DSSTOX compound identifier | DTXCID0025600 |
| P3117 | DSSTox substance ID | DTXSID2045600 |
| P232 | EC number | 627-033-9 |
| P2566 | ECHA Substance Infocard ID | 100.155.382 |
| P234 | InChI | InChI=1S/C21H31N3O5.2H2O/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15;;/h1-3,7-8,16-18,23H,4-6,9-14,22H2,(H,26,27)(H,28,29);2*1H2/t16-,17-,18-;;/m0../s1 |
| P235 | InChIKey | CZRQXSDBMCMPNJ-ZUIPZQNBSA-N |
| P2840 | NSC number | 751176 |
| P2840 | NSC number | 758151 |
| P11199 | Probes And Drugs ID | PD012438 |
| P662 | PubChem CID | 5362118 |
| P1579 | Reaxys registry number | 9460785 |
| P3345 | RxNorm CUI | 29046 |
| P2877 | SureChEMBL ID | 542591 |
| P11089 | UniChem compound ID | 713638 |
| P652 | UNII | E7199S1YWR |
Why not click here or view trends?
log id: 2270235